Skip to main content

Table 1 Baseline and treatment variables in anemic and non-anemic patient groups

From: A retrospective study: the prevalence and prognostic value of anemia in patients undergoing radiotherapy for esophageal squamous cell carcinoma

 

Anemic

Non-anemic

P value

Age (years)

61 (41-82)

60 (45-83)

0.796

Male:female

27:3

64:9

0.738

Hemoglobin (g/dl)

Male

11.4 (8.6-11.9)

13.95 (12.0-15.8)

0.000

Female

10.3 (8.1-10.8)

13.1 (11.7-14.6)

0.000

Tumor location

Cervical

5

8

0.548

Upper

7

14

Middle

11

38

Low

7

13

Treatment modality

Radiotherapy

11

21

0.519

Surgery + radiotherapy

9

31

Chemoradiotherapy

5

7

Surgery + Chemoradiotherapy

5

14

TNM stage

I

3

4

0.296

II

13

31

III

11

36

IV

3

2

T stage

T1

3

8

0.155

T2

9

13

T3

17

38

T4

1

14

Status of lymph nodes

Negative

11

34

0.390

Positive

19

39

Values are shown as median (range) or number, as appropriate.